Staphylococcal diseases

Last updated: January 9, 2022

Summarytoggle arrow icon

Staphylococci are gram-positive, spherical-shaped bacteria that form clusters and are commonly found on the skin and mucous membranes. Clinically, the most important species include Staphylococcus aureus and Staphylococcus epidermidis, which are categorized according to their coagulase activity. S. aureus is coagulase positive and expresses several virulence factors which support evasion of the host immune response. S. epidermidis is coagulase negative and is usually less virulent, although it can evade the host immune system by forming and subsequently hiding in a biofilm. S. aureus is commonly responsible for many localized infections (e.g., folliculitis, cervical lymphadenopathy) and also severe organ infections in the setting of bacteremia (e.g., endocarditis, osteomyelitis). As a toxin producer, S. aureus can cause food poisoning (see Staphylococcal food poisoning) and, in severe cases, life-threatening diseases such as staphylococcal scalded skin syndrome (SSSS) or toxic shock syndrome (TSS). Methicillin-resistant S. aureus (MRSA), in particular, poses a major threat to both immunocompromised and multimorbid patients and is a considerable challenge to hospital hygiene. S. epidermidis is mostly responsible for foreign body infections caused by, for example, contaminated peripheral lines or prosthetic joints. The treatment of choice is anti-staphylococcal penicillins (e.g., oxacillin, flucloxacillin) or first and second-generation cephalosporins.

Definitiontoggle arrow icon

Staphylococci are immotile, gram-positive bacteria that have a round shape and are found in clusters.

Epidemiologytoggle arrow icon

  • Approx. 30% of the general human population are long-term carriers of S. aureus. [1]
    • Three patterns of carriage have been observed: 20% are permanent carriers, 60% are intermittent carriers, 20% are noncarriers
    • MRSA carrier rates and invasive infections have increased during the last decades.

Epidemiological data refers to the US, unless otherwise specified.

Classificationtoggle arrow icon

Resistance and virulence of staphylococcitoggle arrow icon

Staphylococcus aureus

For more information, see methicillin-resistant Staphylococcus aureus and “Gram-positive cocci” section in the bacteria overview.

Staphylococcus epidermidis

Treatmenttoggle arrow icon

Staphylococcus aureus

Coagulase-negative staphylococcus (particularly S. epidermidis)

Subtypes and variantstoggle arrow icon


Ear, nose, and throat

Lymphatic system

Systemic infections

Staphylococci are the most common causative pathogen of infective endocarditis!

Foreign body infections

Toxin-mediated diseases

Referencestoggle arrow icon

  1. Tong SYC, Davis JS, Eichenberger E, Holland TL, Fowler VG. Staphylococcus aureus Infections: Epidemiology, Pathophysiology, Clinical Manifestations, and Management. Clin Microbiol Rev. 2015; 28 (3): p.603-661.doi: 10.1128/cmr.00134-14 . | Open in Read by QxMD
  2. Xu SX, McCormick JK. Staphylococcal superantigens in colonization and disease. Frontiers in Cellular and Infection Microbiology. 2012; 2.doi: 10.3389/fcimb.2012.00052 . | Open in Read by QxMD
  3. Ghasemian A, Najar Peerayeh S, Bakhshi B, Mirzaee M. The Microbial Surface Components Recognizing Adhesive Matrix Molecules (MSCRAMMs) Genes among Clinical Isolates of Staphylococcus aureus from Hospitalized Children.. Iranian journal of pathology. 2015; 10 (4): p.258-64.

Icon of a lock3 free articles remaining

You have 3 free member-only articles left this month. Sign up and get unlimited access.
 Evidence-based content, created and peer-reviewed by physicians. Read the disclaimer